Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pam R Taub

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Current Treatment Options in Cardiovascular Medicine|October 13, 2015
Cardiovascular Benefits of Dark Chocolate?Erin Higginbotham, Pam R Taub
Cell Reports. Medicine|June 22, 2022
Time for better time-restricted eating trials to lessen the burden of metabolic diseasesPam R Taub, Satchidananda Panda
Kardiologia Polska|April 11, 2018
The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failureIwona Swiatkiewicz, Pam R Taub
Coronary Artery Disease|April 7, 2021
Baseline testosterone level may modulate statin efficacyIrvin Xu, Pam R Taub
European Heart Journal|March 28, 2026
Two to Tango: Lipoprotein(a) and Hormonal Status as Determinants of Venous Thromboembolism RiskPam R Taub, Harpreet S Bhatia
Nutrients|January 20, 2021
Time-Restricted Eating and Metabolic Syndrome: Current Status and Future PerspectivesIwona Świątkiewicz, Alina Woźniak, Pam R Taub
The Medical Clinics of North America|March 1, 2022
Heart-Healthy Diets and the Cardiometabolic JackpotCameron K Ormiston, Ashley Rosander, Pam R Taub
Current Cardiology Reports|January 15, 2013
Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetesPam R Taub, Erin Higginbotham, Robert R Henry
Journal of the American College of Cardiology|June 18, 2021
Reply: Ivabradine in POTS: Increase in Central Pressure Rather Than Down-Regulation of Sympathetic Nervous SystemPam R Taub, Adena Zadourian, Jonathan C Hsu
Congestive Heart Failure (Greenwich, Conn.)|July 27, 2010
Biomarkers of heart failurePam R Taub, Paulette Gabbai-Saldate, Alan Maisel
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Current Treatment Options in Cardiovascular Medicine|October 13, 2015
Cardiovascular Benefits of Dark Chocolate?Erin Higginbotham, Pam R Taub
Cell Reports. Medicine|June 22, 2022
Time for better time-restricted eating trials to lessen the burden of metabolic diseasesPam R Taub, Satchidananda Panda
Kardiologia Polska|April 11, 2018
The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failureIwona Swiatkiewicz, Pam R Taub
Coronary Artery Disease|April 7, 2021
Baseline testosterone level may modulate statin efficacyIrvin Xu, Pam R Taub
European Heart Journal|March 28, 2026
Two to Tango: Lipoprotein(a) and Hormonal Status as Determinants of Venous Thromboembolism RiskPam R Taub, Harpreet S Bhatia
Nutrients|January 20, 2021
Time-Restricted Eating and Metabolic Syndrome: Current Status and Future PerspectivesIwona Świątkiewicz, Alina Woźniak, Pam R Taub
The Medical Clinics of North America|March 1, 2022
Heart-Healthy Diets and the Cardiometabolic JackpotCameron K Ormiston, Ashley Rosander, Pam R Taub
Current Cardiology Reports|January 15, 2013
Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetesPam R Taub, Erin Higginbotham, Robert R Henry
Journal of the American College of Cardiology|June 18, 2021
Reply: Ivabradine in POTS: Increase in Central Pressure Rather Than Down-Regulation of Sympathetic Nervous SystemPam R Taub, Adena Zadourian, Jonathan C Hsu
Congestive Heart Failure (Greenwich, Conn.)|July 27, 2010
Biomarkers of heart failurePam R Taub, Paulette Gabbai-Saldate, Alan Maisel
Pageof 11